Related Experiment Video
Updated: Aug 6, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer
Sunil Upadhyay1, Chunyan Liu, Aditi Chatterjee
1Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA.
Abstract:
We showed that the PEA3 transcriptional factor interacted with LKB1, a serine/threonine kinase, which is somatically mutated in lung cancer. This interaction occurred through the ETS domain of PEA3 and the kinase domain of LKB1. Mutation of LKB1 in lung cancer cells stabilized PEA3. Reintroduction of wild-type (WT) LKB1 into cells induced down-regulation of PEA3 and subsequently resulted in reduced cyclooxygenase-2 RNA and protein expression, whereas germ-line and somatic LKB1 mutants were defective in this activity. LKB1 phosphorylated PEA3 and promoted its degradation through a proteasome-mediated mechanism. Cells expressing mutant LKB1 possessed greater invasive potential compared with cells expressing WT LKB1. Increased invasion of cells with mutant LKB1 was partly due to PEA3 expression, as RNA interference inhibition of PEA3 resulted in dramatic decrease of Matrigel invasion. However, forced expression of PEA3 resulted in down-regulation of epithelial markers and induction of mesenchymal markers. These results suggest that PEA3 stabilization due to LKB1 inactivation could lead to epithelial/mesenchymal transition and greater lung cancer invasion potential.
Insights
Inactivation of LKB1 (a tumor suppressor) in lung cancer stabilizes PEA3, promoting cell invasion. Restoring wild-type LKB1 reduces PEA3, inhibiting cancer progression and epithelial-mesenchymal transition.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- LKB1 (serine/threonine kinase) is frequently mutated in lung cancer.
- PEA3 is a transcriptional factor implicated in cancer progression.
Purpose of the Study:
- To investigate the interaction between PEA3 and LKB1 in lung cancer.
- To elucidate the role of this interaction in lung cancer cell invasion and epithelial-mesenchymal transition.
Main Methods:
- Co-immunoprecipitation to study protein interactions.
- Western blotting to assess protein expression and degradation.
- Quantitative real-time PCR for gene expression analysis.
- Matrigel invasion assays to evaluate cell invasiveness.
- RNA interference to inhibit PEA3 expression.
Main Results:
- LKB1 directly interacts with PEA3 via its ETS and kinase domains, respectively.
- LKB1 phosphorylates PEA3, targeting it for proteasomal degradation.
- LKB1 mutations stabilize PEA3, leading to increased cyclooxygenase-2 expression.
- PEA3 stabilization in mutant LKB1 cells correlates with enhanced invasion and epithelial-mesenchymal transition.
- Inhibition of PEA3 significantly reduces invasion in LKB1-mutant lung cancer cells.
Conclusions:
- LKB1 inactivation in lung cancer leads to PEA3 stabilization.
- Stabilized PEA3 promotes lung cancer cell invasion and epithelial-mesenchymal transition.
- Targeting the LKB1-PEA3 axis may offer therapeutic strategies for lung cancer.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation